feed,title,long_url,short_url
MedRxiv,"RNA polymerase inhibitor enisamium for treatment of moderate COVID-19 patients: a randomized, placebo-controlled, multicenter, double-blind phase 3 clinical trial",https://medrxiv.org/cgi/content/short/2022.08.21.22279036v1?rss=1,https://bit.ly/3AGWL9j
